International Conference on Viral Hepatitis 2014
The 2014 International Conference on Viral Hepatitis was jointly sponsored by the International Association of Providers of AIDS Care (IAPAC) and the Icahn School of Medicine at Mount Sinai, in partnership with the International Association for the Study of the Liver (IASL). The conference was Co-Chaired by Dr. Douglas T. Dieterich (Icahn School of Medicine at Mount Sinai, New York, NY, USA), Dr. Mario U. Mondelli (University of Pavia, Pavia, Italy), and Dr. Mark R. Nelson (Chelsea & Westminster Hospital, London, England). Following are conference presentations. The conference organizers request that any use of these presentations should include citations to both their presenting authors and relevant conference information (e.g., 2014 International Conference on Viral Hepatitis, March 17-18, 2014, New York).
MONDAY, March 17, 2014
PLENARY 1 – Global Snapshot of Viral Hepatitis Morbidity and Mortality
Kiren Mitruka, MD, MPH, US Centers for Disease Control and Prevention, Atlanta, GA, USA
KEYNOTE ADDRESS – The HCV Epidemic and Its Cure(s): Placing the State of the Science into Much-Needed Context and Perspective
Mario U. Mondelli, MD, PhD, University of Pavia, Pavia, Italy
PLENARY 2 – HBV State-of-the-Science
Tram T. Tran, MD, Cedars-Sinai Medical Center, Los Angeles, CA, USA
PLENARY 3 – HCV State-of-the-Science
Massimo Puoti, MD, AO Ospedale Niguarda Cà Granda, Milan, Italy
PANEL DISCUSSION 1 – Patient Perspectives on What Providers Need to Know about Stigma and other Barriers to Hepatitis Care
Moderator: Helen-Maria Lekas, PhD, Columbia University, New York, NY, USA
Panelist 1: Jules Levin, National AIDS Treatment Advocacy Project, New York, NY, USA
Panelist 2: Gloria Searson, ACSW, Coalition on Positive Health Empowerment, New York, NY, USA
Panelist 3: Alyson Harty, RN, Mount Sinai Medical Center, New York, NY, USA
Panelist 4: William Thompson, New York, NY
PLENARY 4 – Recognizing Advanced Liver Disease for the New HCV Treater
Kosh Agarwal, MD, King’s College Hospital, London, England
PLENARY 5 – HIV Infection with HCV Future Directions
Ranjababu Kulasegaram, MD, FRCP, Guy’s and St. Thomas’ NHS Foundation Trust, London, England
PLENARY 6 – Hepatocellular Carcinoma — State of the Science Review
Sasan Roayaie, MD, Hofstra North Shore-LIJ School of Medicine, Manhasset, NY, USA
PLENARY 7 – Liver Transplant in HIV — Reopening the Debate
K. Rajender Reddy, MD, University of Pennsylvania, Philadelphia, PA, USA
TUESDAY, March 18, 2014
PANEL DISCUSSION 2 – Strengthening the HCV Continuum of Care
Moderator: Mario U. Mondelli, MD, PhD
Presenter: Fabienne Laraque, MD, MPH, The New York City Department of Health and Mental Hygiene, New York, NY, USA Presentation
Discussants: Kosh Agarwal, MD, King’s College Hospital, London, England
Jeffrey Kwong, DNP, MPH, ANP-BC, Columbia University, New York, NY, USA
Federico G. Villamil, MD, British Hospital of Buenos Aires, Buenos Aires, Argentina
PLENARY 8 – Key Issues in Drug Interactions in the Direct-Acting Antiviral Era
David J. Back, PhD, University of Liverpool, Liverpool, England
PLENARY 9 – Adherence in the Age of HCV Antiviral Therapy
Jeffrey Weiss, PhD, Icahn School of Medicine at Mount Sinai, New York, NY, USA
PANEL DISCUSSION 3 – Managing Viral Hepatitis in Primary Health Care Settings and Exploring the Role of Non-Physician Clinicians
Moderator: Jeffrey Kwong, DNP, MPH, ANP-BC, Columbia University, New York, NY, USA
Panelist 1: Sherilyn Brinkley, CRNP, Johns Hopkins University, Baltimore, MD, USA Presentation
Panelist 2: Donald Gardenier, DNP, FNP-BC, Icahn School of Medicine at Mount Sinai, New York, NY, USA Presentation
Panelist 3: Michelle T. Martin, PharmD, BCPS, BCACP, University of Illinois, Chicago, IL, USA Presentation
Panelist 4: Jeffrey Weiss, PhD, Icahn School of Medicine at Mount Sinai, New York, NY, USA Presentation
CASE STUDY SESSION – Complicated Cases
Acute and Chronic HBV/HCV
Alex Salam, MBChB, MSc, MRCP, Chelsea and Westminster Hospital, London, England
Antiviral Therapy Before and After Liver Transplantation
Federico G. Villamil, MD, British Hospital of Buenos Aires, Buenos Aires, Argentina
CASE STUDY SESSION – Vulnerable Populations
Children and Adolescents
Ivana Carey, MD, PhD, King’s College London, London, England
PANEL DISCUSSION 4 – Reinfection: A Limiting Factor for HCV Treatment as Prevention?
Moderator: Mark R. Nelson, MD, Chelsea & Westminster Hospital, London, England
Presenter: Thomas C.S. Martin, MS, MA, BMBCh, MRCP, Chelsea & Westminster Hospital, London, England Presentation
Discussant: Natasha Martin, PhD, University of Bristol, Bristol, England Presentation
PLENARY 10 – Pregnancy and Hepatitis – An Underestimated Clinical Management Issue
Tram T. Tran, MD, Cedars-Sinai Medical Center, Los Angeles, CA, USA
PLENARY 11 – The Future of HCV in Men who have Sex with Men
Emma Page, MBBS, MRCP, Chelsea & Westminster Hospital, London, England
RAPPORTEUR SESSION AND 2 TOP-RATED ABSTRACTS – Bridging Barriers to Improve Viral Hepatitis Patient Outcomes in Diverse Communities and Populations
Douglas T. Dieterich, MD, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Mark R. Nelson, MD, Chelsea & Westminster Hospital, London, England
Mario U. Mondelli, MD, PhD, University of Pavia, Pavia, Italy
ORAL ABSTRACT PRESENTATIONS
48 – Hepatitis C Screening, Retesting, and Treatment Discussion among HIV-Positive Persons in Care, 2011
Bruce Agins presenting
49 – Does the Addition of HCV Testing to a Rapid HIV Testing Program Impact HIV Test Acceptance? A Randomized Controlled Trial
Sara Rahman presenting
50 – Elevated Mortality Risk in HIV/HCV-Coinfected Patients: Risk Assessment Using the VACS Index
Oluwatoyin Adeyemi presenting
51 – New All Oral Therapy for Chronic Hepatitis C Virus (HCV): A Cost-Benefit Analysis
Jennifer Orsi presenting
54 – Patient Management Programs Lead to Improved Adherence for Patients with Hepatitis C using Drug Dual Therapy in Both Retail and Central Pharmacies
Jennifer Orsi presenting on behalf of Francis Staskon
55 – Perceptions of Genetic Testing and Genomic Medicine as Part of Hepatitis C Care among Urban Drug Users
David Perlman presenting
57 – The CORE HCV Cascade: Evaluating Gaps in Hepatitis C Virus (HCV) Evaluation in HIV/HCV Coinfected Patients
Oluwatoyin Adeyemi presenting
59 – High Yield and Feasibility of HCV Birth Cohort Screening in Two Urban, Academic Emergency Departments
James Galbraith presenting
60 – The Role of Social Work in an Interdisciplinary, Hepatitis C Treatment Team
Catherine Amory presenting
61 – HCV Care Cascade Outcomes in a Non-Clinical, Neighborhood-Based Testing and Linkage Program
Stacey Trooskin presenting
62 – Primary Care-Based Hepatitis C Treatment in the First Generation Triple Therapy Era
Keith M. Sigel presenting
63 – Economics of Rapid Hepatitis C Screening in Correctional Facilities
John Wong presenting
65 – Use of In-Care Viral Load to Assess Care of Hepatitis C in the District of Columbia
Monique Millington presenting
67 – Hepatitis C Capacity Strengthening Program with Aboriginal Medical Services In Regional Australia
Beth Wilson presenting
<!–
Click here to receive an email notice regarding next year’s International Conference on Viral Hepatitis.
–>
2014 Conference Program and Abstracts
Click below to download the complete 2014 Program in PDF format.
Requires free Acrobat Reader Plugin Software
